Title of article :
Management of Ovarian Yolk Sac Tumor in Pregnancy in a Limited Resource Setting: Case Report
Author/Authors :
Widya Utami, Tofan Obstetrics and Gynecology Department Faculty of Medicine - Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia , Suwartono, Herdhana Obstetrics and Gynecology Department Faculty of Medicine - Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia , Ayu Umami, Erda Obstetrics and Gynecology Department Faculty of Medicine - Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia , Mahardika, Anggara Obstetrics and Gynecology Department Faculty of Medicine - Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia , Surya, Raymond Obstetrics and Gynecology Department Faculty of Medicine - Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia , Nurana, Laila Obstetrics and Gynecology Department Faculty of Medicine - Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Pages :
5
From page :
597
To page :
601
Abstract :
Ovarian yolk sac tumor in pregnancy is a very rare case (<5%). The management could be very challenging since studies regarding the disease are very limited. This case report is written in order to report a rare case of yolk sac tumor in pregnancy and its management. A 29-year-old woman with a 16 weeks gestational age (WGA) in her first pregnancy presented in the emergency room with severe lower abdominal pain. Next, she underwent exploratory laparotomy, and a biopsy was performed, which indicated an ovarian yolk sac tumor. The patient was then given neoadjuvant chemotherapy with carboplatin and paclitaxel. The pregnancy resulted in an intrauterine growth restriction (IUGR) baby, delivered on 33 WGA. The baby was delivered through C-section and the mother continued to undergo optimally debulked laparotomy, total hysterectomy, bilateral salphingo-oophorectomy, omentectomy, and rectosigmoid tumor resection. In dealing with a rare case with limited resources, tailor-made management is required. The most ideal treatment may not be performed, but the clinician should be more adaptive for the patient to have a better outcome.
Keywords :
Ovarian yolk sac tumor , Neoadjuvant chemotherapy , Intrauterine growth restriction
Journal title :
Middle East Journal of Cancer (MEJC)
Serial Year :
2021
Record number :
2720071
Link To Document :
بازگشت